SERES THERAPEUTICS INC (MCRB) Institutional Ownership
None of the superinvestors we track currently report SERES THERAPEUTICS INC (MCRB) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in SERES THERAPEUTICS INC (MCRB), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2023 | 1 | $1,144 | 817,000 |
| Q1 2023 | 1 | $2,258 | 398,200 |
| Q4 2022 | 1 | $3,088 | 551,500 |
| Q3 2022 | 1 | $3,460 | 538,900 |
| Q2 2022 | 1 | $3,006 | 876,407 |
| Q1 2022 | 1 | $3,413 | 479,400 |
| Q4 2021 | 1 | $6,218 | 746,500 |
| Q2 2021 | 1 | $231,659 | 9,713,160 |
| Q1 2021 | 2 | $246,774 | 11,985,147 |
| Q4 2020 | 2 | $339,136 | 13,842,254 |
| Q3 2020 | 2 | $358,683 | 12,669,841 |
| Q2 2020 | 2 | $66,032 | 13,872,242 |
Related MCRB Institutional Insights:
- MCRB Institutional Ownership & Insiders Activity
- MCRB Institutional Ownership & 13F Activity
- MCRB Top Institutional Shareholders
- MCRB Institutional Buying Activity
- MCRB Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- MCRB Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings